Expired Pfizer Paxlovid doses set to cost Europe $2.2B, FT reports

Expired doses of Pfizer’s Covid-19 antiviral drugs are set to cost Europe about $2.2B, The Financial Times’ Hannah Kuchler reports, citing data from analytics group Airfinity. By the end of February, a total of about 3.1mn courses are set to expire, according to the report. Marco Gallotta, an analyst at Airfinity, said some countries may have overpurchased Paxlovid when it became available at the end of 2021, just as the Omicron variant increased global caseloads, but a drop in cases and a reduction in testing hit the take-up of antiviral drugs.